Form D · Biotechnology
MONTERIS MEDICAL HOLDINGS, INC
Plymouth, MN · CIK 0001432360
Offering snapshot reported Oct 16, 2013 · SEC filing
- Reported sold
- $3.67M Offering amount: $3.67M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 2, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 16, 2013 | Initial | $3,672,684 | No comparison | 7 | SEC filing |
| Jun 18, 2010 | Initial | $3,368,460 | No comparison | 2 | SEC filing |
| Sep 21, 2009 | Initial | $2,000,000 | No comparison | 2 | SEC filing |
| Apr 10, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-204644
Source: Form D, filed Oct 16, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gary Bantle | Director |
| Gregory Barrett | Director |
| Daniel Cole | Director |
| Robert K Davidson | Executive |
| Jim Duncan | Director, Executive |
| Kevin Mc Garry | Director |
| Patrick Morand | Director |
| James Richardson | Director |
| Jim Richmond | Director |
| John Schellhorn | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
16305 36th Avenue North Suite 200
Plymouth, MN, 55446
Plymouth, MN, 55446